SHERIDAN, WYOMING – May 8, 2025 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, has announced its financial results for the first quarter of 2025. Despite navigating a challenging macroeconomic landscape, the company demonstrated solid operational performance, underscoring its commitment to driving growth and margin expansion amidst market volatility.

SHERIDAN, WYOMING – May 8, 2025 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a recognized leader in life science research and clinical diagnostics products, is set to announce its first-quarter financial results for 2025 on Thursday, May 1, 2025. The company will release its earnings after market close, followed by a detailed conference call to discuss the results.

SHERIDAN, WYOMING – May 8, 2025 – GN Store Nord A/S has announced a notification under Article 19 of Regulation (EU) No. 596/2014 regarding share transactions carried out by individuals in managerial roles at the company. The transaction was made by Søren Jelert, the company’s Chief Financial Officer (CFO), as part of his regular financial management activities. This report includes details on the purchase of GN Store Nord shares, shedding light on the executive’s commitment to the company and the ongoing market activity surrounding its stock.

SHERIDAN, WYOMING – May 8, 2025 – GN Store Nord A/S has reported its Q1 2025 financial results, highlighting a mix of challenges and opportunities. The company's growth was impacted by market uncertainties, including global macroeconomic pressures and changes in consumer sentiment, particularly in the U.S. Despite these hurdles, GN has initiated proactive cost mitigation strategies aimed at ensuring long-term profitability and supporting margin growth.

SHERIDAN, WYOMING – May 8, 2025 – GN Store Nord A/S has announced a series of strategic measures to mitigate the adverse effects of increased tariff levels, recently imposed by the U.S. administration. These proactive actions are designed to protect the company’s EBITA margin for 2025 and secure long-term earnings growth despite the heightened uncertainty in the global trade environment.

SHERIDAN, WYOMING – May 8, 2025 – In recognition of International Women in Tech Day, GN celebrates the contributions of women who are advancing technology across industries. As a leader in hearing, gaming, and professional audio and video equipment, GN takes pride in showcasing the exceptional women driving innovation in these fields. The day underscores the importance of diversity in the tech sector, highlighting how women’s contributions are shaping products and services that meet diverse needs and drive business growth.

SHERIDAN, WYOMING – May 8, 2025 – Sennheiser has unveiled its latest innovation, the ACCENTUM Open, a true wireless earbud designed for multitaskers who need both clear sound and awareness of their surroundings. Combining Sennheiser's renowned sound tuning with an open, non-occlusive fit, the ACCENTUM Open provides a simple and efficient way to stay connected to both entertainment and the outside world.

SHERIDAN, WYOMING – May 8, 2025 – Hansaton, a leading name in innovative hearing solutions, has unveiled the Hansaton Essenz platform, introducing the first product in the lineup: sound E-R, a cutting-edge receiver-in-canal (RIC) hearing aid. Designed to provide unparalleled sound quality from the very first use, the sound E-R promises exceptional comfort, reliability, and ease of use. Featuring a sleek, modern design and a convenient magnetic charger, this hearing aid is the perfect companion for those on the go or at home.

SHERIDAN, WYOMING – May 8, 2025 – Cochlear North America has been recognized with the prestigious Silver Award from Cigna's Healthy Workforce Designation for 2024. This esteemed honor reflects the company's ongoing commitment to promoting a supportive and healthy work environment for its employees. With a focus on mental health, physical fitness, and work-life balance, Cochlear North America's wellness initiatives continue to set a benchmark for employee well-being.

SHERIDAN, WYOMING – May 7, 2025 – Convatec, a global leader in medical technologies focused on chronic condition management, has received regulatory approval for ConvaNiox™, a first-of-its-kind nitric oxide-generating multimodal dressing technology. This innovative product aims to significantly improve outcomes for patients with diabetic foot ulcers (DFUs), offering a powerful solution to an underserved segment of the wound care market.